OBSERVATION ON CHANGES OF ERYTHROCYTE POLYAMINE LEVELS IN LEUKEMIA PATIENTS

）（P<0.01）, 0.319 in APL （P<0.001） and0.296 in AMoL and AMMoL （P<0.001）, and the differences between the Spd/Spm ra-tio in AMoL and AMMoL and in ALL were noted （P<0.05）; （5） Spd and Spm le-vels in erythrocytes in the patients after effective chemotherapy declined significantly（P<0.05） but were still higher than control value （P<0.025）. These results suggestthat the determination of erythrocyte polyamines in leukemia patients may be helpful indiagnosis, differential diagnosis and prognosis.